EN
登录

对话式AI平台Hyro获得B轮延期融资,支持GPT的会话AI工具

Hyro secures Series B extension for GPT-enabled conversational AI tool

MobiHealthNews 等信源发布 2024-12-10 18:24

可切换为仅中文


Photo: miniseries/Getty Images

照片:迷你剧/盖蒂图片

GPT-enabled conversational AI provider Hyro announced it finalized an extension of its Series B funding round. The company told MobiHealthNews that the total Series B funding equates to $35 million, bringing the company's total raise to $50 million.

GPT支持的对话AI提供商Hyro宣布,它最终确定了B轮融资的延期。该公司告诉MobiHealthNews,B系列融资总额相当于3500万美元,使公司的总筹资额达到5000万美元。

Healthier Capital led the extension, joining the company's previous investors, Liberty Mutual, Macquarie Capital and Black Opal Ventures.

更健康的资本(HealthCapital)领导了这一扩展,加入了该公司之前的投资者,自由互惠银行(Liberty Mutual)、麦格理资本(Macquarie Capital)和Black Opal Ventures。

Amir Dan Rubin founded Healthier Capital. He previously served as CEO of Amazon's One Medical, executive vice president at Optum / UnitedHealth Group, and CEO at Stanford Health Care.

阿米尔·丹·鲁宾创立了健康资本。他曾担任亚马逊One Medical的首席执行官、Optum/UnitedHealth Group的执行副总裁以及斯坦福医疗保健公司的首席执行官。

WHAT IT DOES

它的功能

New York-based Hyro offers a conversational AI-enabled call center for providers that allows for automated conversations with their patients. It also provides real-time analytics, insights from patient interactions and a GPT-powered assistant, dubbed Spot, that offers explainability around AI outputs..

总部位于纽约的Hyro为供应商提供了一个对话式人工智能呼叫中心,可以与患者进行自动对话。它还提供实时分析、来自患者互动的见解以及GPT支持的助手(称为Spot),该助手可以解释AI输出。。

The company plans to expand its healthcare footprint and introduce tools for the payer and pharmaceutical markets. In a statement, it said it will expand its outbound calling offering next year, focusing on appointment no-shows and 'encourage patients to switch from reactive to proactive care.' It will also enhance its analytics suite.  .

该公司计划扩大其医疗足迹,并为付款人和制药市场引入工具。该公司在一份声明中表示,明年将扩大外呼服务,重点关注预约不显示,并“鼓励患者从被动护理转向主动护理”它还将增强其分析套件。。

'Healthier Capital's investment is yet another signal to the market of the steadfast trust we've established in our ability to deliver stellar outcomes at Hyro, catching the attention of Healthier Capital's founder, Amir Dan Rubin, after his tenure in healthcare innovation. We are thrilled to have the Healthier Capital team in our corner,' Israel Krush, CEO and cofounder of Hyro, said in a statement. .

“healthcare Capital的投资向市场发出了另一个信号,表明我们对我们在Hyro取得卓越成果的能力建立了坚定的信任,这引起了healthcare Capital创始人阿米尔·丹·鲁宾(Amir Dan Rubin)在医疗创新领域任职后的注意。Hyro首席执行官兼联合创始人以色列·克鲁斯(IsraelKrush)在一份声明中表示,我们很高兴拥有一支更健康的资本团队。

MARKET SNAPSHOT

市场快照

Last year, Hyro raised $20 million in Series B funding led by Macquarie Capital, which it said it would use to expand its workforce, grow strategic partners and further build its platform.

去年,Hyro在麦格理资本(Macquarie Capital)牵头的B轮融资中筹集了2000万美元,该公司表示将利用这笔资金扩大员工队伍,发展战略合作伙伴,并进一步构建平台。

The company also announced a partnership with patient communication platform Artera, formerly Well Health, to launch Artera Care Assist, an AI-powered virtual assistant powered by Hyro that can be embedded into a health provider's website to answer common patient questions.

该公司还宣布与患者沟通平台Artera(前身为Well Health)建立合作关系,推出Artera Care Assist,这是一种由Hyro提供动力的人工智能虚拟助理,可以嵌入健康提供者的网站中,以回答患者常见的问题。

In 2019, Hyro, formerly Airbud, raised $4 million in seed funding and, in 2021, secured $10.5 million in Series A funding.

2019年,Hyro(前身为Airbud)筹集了400万美元的种子资金,并于2021年获得了1050万美元的A系列资金。

Tags: Hyro, conversational AI

标签:Hyro,对话AI

More regional news

更多地区新闻

Qi Biodesign secures $75M for genome editing changesBy Anthony VecchioneDecember 10, 2024

Qi Biodesign为安东尼·维奇奥尼(AnthonyVecchione2024年12月10日)的基因组编辑更改获得7500万美元

Q&A: Hackensack Meridian Health on its AI expenditures in 2025By Anthony VecchioneDecember 10, 2024

问答:哈肯萨克Meridian Health公司2025年人工智能支出安东尼·维奇奥尼2024年12月10日

Cala Health raises $50M to expand wearable tremor therapyBy Jessica HagenDecember 09, 2024

Cala Health筹集5000万美元用于扩展可穿戴式震颤治疗,Jessica Hagende2024年12月9日